Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017

Sheena G. Sullivan, Monique B. Chilver, Kylie S. Carville, Yi Mo Deng, Kristina A. Grant, Geoff Higgins, Naomi Komadina, Vivian K.Y. Leung, Cara A. Minney-Smith, Don Teng, Thomas Tran, Nigel Stocks, James E. Fielding

Research output: Contribution to journalArticleResearchpeer-review

Abstract

In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1) pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.

Original languageEnglish
Number of pages7
JournalEurosurveillance
Volume22
Issue number43
DOIs
Publication statusPublished - 26 Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this